pharmaceuticals

Ozempic maker says pilots will start across R&D, manufacturing and commercial operations, with full integration due by end-2026

Delhi High Court pauses Olymviq rollout after Novo Nordisk argues the name is too close to Ozempic just days after semaglutide patent protection expired in India.

Credit ratings agency says capital-heavy sectors from utilities to pharma will see slower AI adoption while cloud, chips and data services emerge as winners.